	Novo, Lilly race for supremacy in India's anti-obesity drug market
	Here’s how to get GLP-1 drugs covered by employer health insurance
	As anti-obesity drug Wegovy launches in India, patients share experience using drugs like Mounjaro; doctors weigh in effectiveness
	A Former FDA Commissioner’s Path To Weight Management
	Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs
	Viking: I'm Bullish On Oral/Injectable GLP-1 Obesity Data Catalysts
	Experimental new drug could literally 'burn fat' as clinical trial shows weight loss
	Novo Nordisk Launches Anti-obesity Drug Wegovy in India